Search Results

Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study

• Authors : Amrouch, Cheima, Author; Vetrano, Davide L., Author; De Bacquer, Dirk, Author ...

Subjects: Adverse clinical outcomes; Atrial fibrillation; Drug-drug interactions

• Source: Cardiovascular Drugs and Therapy.

Record details

Development of an Empirical Approach for the Prediction of Cytochrome P450-Based Drug–Drug Interactions in Pediatric Patients.

• Authors : Di Paolo, Veronica¹ (AUTHOR) ; Ferrari, Francesco Maria² (AUTHOR); Poggesi, Italo³ (AUTHOR)

• Source: Pharmaceuticals (14248247). Apr2026, Vol. 19 Issue 4, p608. 13p.

Record details

Physiologically‐Based Pharmacokinetic Model‐Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors.

• Authors : Riad, Md Mahbubul Huq¹ (AUTHOR); Marroum, Patrick¹ (AUTHOR); Shebley, Mohamad¹ (AUTHOR)

• Source: CPT: Pharmacometrics & Systems Pharmacology. Apr2026, Vol. 15 Issue 4, p1-10. 10p.

Record details

Evaluation of Potential Drug–Drug Interactions in Cardiac Inpatients at a Tertiary Care Hospital: A Cross-sectional Study.

• Authors : V. H., Pushpa¹ (AUTHOR); Pareek, Shurti¹ (AUTHOR); M., Manjappa² (AUTHOR)

• Source: Journal of Pharmacology & Pharmacotherapeutics. Jun2026, Vol. 17 Issue 2, p214-219. 6p.

Record details

Prevalence and profile of potential drug-drug interactions in hospitalized pediatric patients: A cross-sectional study.

• Authors : Camacho-Cruz, Jhon¹; Bibiana Castro-Báez, July¹; Fernando Ramírez-Cruz, Cristian¹

• Source: Revista Colombiana de Ciencias Químico-Farmacéuticas. 2026, Vol. 55 Issue 2, p519-527. 9p.

Record details

Prevalence, predictors, and clinical relevance of drug–drug interactions in outpatient prescribing: A national cross-sectional study.

• Authors : Aarabi, Seyed Sahab^1,2 (AUTHOR); Semnani, Farbod^1,2 (AUTHOR); Aminzade, Zahra^1,3,4 (AUTHOR)

• Source: PLoS ONE. 4/8/2026, Vol. 21 Issue 4, p1-19. 19p.

Record details

The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens.

• Authors : Stankeviciute, Simona¹ ; Tsai, Ariel²; Rayad, Noha³

• Source: Translational & Clinical Pharmacology. Mar2026, Vol. 34 Issue 1, p1-14. 14p.

Record details

Onco-Hem Connectome—Network-Based Phenotyping of Polypharmacy and Drug–Drug Interactions in Onco-Hematological Inpatients.

• Authors : Vasii, Sabina-Oana^1,2 (AUTHOR); Colibășanu, Daiana^1,2,3 (AUTHOR); Goldiș, Florina-Diana^1,2,3 (AUTHOR)

• Source: Pharmaceutics. Feb2026, Vol. 18 Issue 2, p146. 22p.

Record details

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection.

• Authors : Dybowska, Dorota¹ (AUTHOR) ; Pawłowska, Małgorzata¹ (AUTHOR); Kozielewicz, Dorota¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p87. 13p.

Record details

Quantifying the effects of mucociliary clearance and cilia–drug interactions on partial drug dissolution and epithelial deposition in the airway surface liquid

• Authors : Sedaghat, Mohammad Hadi, Author; Anagnostopoulou, Pinelopi, Author; Abouali, Omid, Author ...

Subjects: Airway surface liquid; Drug–cilia interaction; Mucociliary clearance

• Source: International Journal of Pharmaceutics. 692

Record details